Nagai Rajendran
Urology · Yonkers, NYNPI 1639194855
Payments from drug & device makers
Across 142 payments — averaging $28.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Astellas Pharma US Inc$653
- Urovant Sciences Inc$405
- AbbVie$309
- Aytu Biopharma, Inc.$216
- Endo Pharmaceuticals Inc.$212
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,72692%
- Education$3328%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 49 | $1,077 |
| Astellas Pharma US Inc | 21 | $653 |
| Urovant Sciences Inc | 10 | $405 |
| AbbVie(2 entities) | 9 | $309 |
| Aytu Biopharma, Inc. | 2 | $216 |
| Endo Pharmaceuticals Inc. | 5 | $212 |
| Myovant Sciences Inc. | 8 | $188 |
| Sumitomo Pharma America, Inc. | 5 | $134 |
| Avanir Pharmaceuticals, Inc. | 1 | $115 |
| Therapeuticsmd, Inc. | 1 | $70 |
| Blue Earth Diagnostics | 3 | $69 |
| Axonics, Inc. | 1 | $60 |
| Pfizer | 3 | $57 |
| Myriad Genetic Laboratories, Inc. | 3 | $55 |
| Novo Nordisk | 2 | $43 |
| Merck | 2 | $41 |
| Antares Pharma, Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Procept Biorobotics Corporation | 1 | $35 |
| Acerus Pharmaceuticals Corporation | 1 | $34 |
| Neotract Inc. | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Clarus Therapeutics Inc. | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Coloplast | 1 | $18 |
| Tolmar, Inc. | 1 | $16 |
| Photocure Inc | 1 | $16 |
| Dentsply IH Inc. | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
| Rochester Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,058 in reported general payments places this provider in the 55th percentile of 952 urology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 14 | $9,560 |
| Tamsulosin Hcl | 83 | $1,004 |
| Finasteride | 39 | $519 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $219 |
| Ciprofloxacin Hcl | 15 | $90 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $88 |
| Meloxicam | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $134 | $9,56014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 952 urology providers in New York.
Other urology in Yonkers
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
- Gennady BratslavskySyracuse$2.5M
- Ashutosh TewariNew York$2.5M
- Manish ViraNew Hyde Park$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.